311 related articles for article (PubMed ID: 26434591)
41. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.
Chen TC; Yu J; Nouri Nigjeh E; Wang W; Myint PT; Zandi E; Hofman FM; Schönthal AH
Cancer Lett; 2017 Aug; 400():161-174. PubMed ID: 28450161
[TBL] [Abstract][Full Text] [Related]
42. Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.
Mannowetz N; Wandernoth P; Wennemuth G
J Cell Physiol; 2012 May; 227(5):2154-62. PubMed ID: 21792931
[TBL] [Abstract][Full Text] [Related]
43. Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice.
Pierre K; Parent A; Jayet PY; Halestrap AP; Scherrer U; Pellerin L
J Physiol; 2007 Sep; 583(Pt 2):469-86. PubMed ID: 17599960
[TBL] [Abstract][Full Text] [Related]
44. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
45. MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance.
Marengo B; Garbarino O; Speciale A; Monteleone L; Traverso N; Domenicotti C
Oxid Med Cell Longev; 2019; 2019():7346492. PubMed ID: 31341534
[TBL] [Abstract][Full Text] [Related]
46. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.
Miranda-Gonçalves V; Bezerra F; Costa-Almeida R; Freitas-Cunha M; Soares R; Martinho O; Reis RM; Pinheiro C; Baltazar F
Mol Carcinog; 2017 Dec; 56(12):2630-2642. PubMed ID: 28762551
[TBL] [Abstract][Full Text] [Related]
47. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
Majumdar S; Gunda S; Pal D; Mitra AK
Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
[TBL] [Abstract][Full Text] [Related]
48. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
49. Small molecule selectively suppresses MYC transcription in cancer cells.
Bouvard C; Lim SM; Ludka J; Yazdani N; Woods AK; Chatterjee AK; Schultz PG; Zhu S
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3497-3502. PubMed ID: 28292893
[TBL] [Abstract][Full Text] [Related]
50. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
[TBL] [Abstract][Full Text] [Related]
51. Attacking c-Myc: targeted and combined therapies for cancer.
Huang H; Weng H; Zhou H; Qu L
Curr Pharm Des; 2014; 20(42):6543-54. PubMed ID: 25341931
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis.
Yue M; Jiang J; Gao P; Liu H; Qing G
Cell Rep; 2017 Dec; 21(13):3819-3832. PubMed ID: 29281830
[TBL] [Abstract][Full Text] [Related]
53. Menin enhances c-Myc-mediated transcription to promote cancer progression.
Wu G; Yuan M; Shen S; Ma X; Fang J; Zhu L; Sun L; Liu Z; He X; Huang D; Li T; Li C; Wu J; Hu X; Li Z; Song L; Qu K; Zhang H; Gao P
Nat Commun; 2017 May; 8():15278. PubMed ID: 28474697
[TBL] [Abstract][Full Text] [Related]
54. Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.
Li B; Simon MC
Clin Cancer Res; 2013 Nov; 19(21):5835-41. PubMed ID: 23897900
[TBL] [Abstract][Full Text] [Related]
55. The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas.
D'Andrea A; Gritti I; Nicoli P; Giorgio M; Doni M; Conti A; Bianchi V; Casoli L; Sabò A; Mironov A; Beznoussenko GV; Amati B
Oncotarget; 2016 Nov; 7(45):72415-72430. PubMed ID: 27635472
[TBL] [Abstract][Full Text] [Related]
56. 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.
Liu Z; Sun Y; Hong H; Zhao S; Zou X; Ma R; Jiang C; Wang Z; Li H; Liu H
Am J Cancer Res; 2015; 5(9):2673-85. PubMed ID: 26609475
[TBL] [Abstract][Full Text] [Related]
57. New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
Gottfried E; Lang SA; Renner K; Bosserhoff A; Gronwald W; Rehli M; Einhell S; Gedig I; Singer K; Seilbeck A; Mackensen A; Grauer O; Hau P; Dettmer K; Andreesen R; Oefner PJ; Kreutz M
PLoS One; 2013; 8(7):e66987. PubMed ID: 23874405
[TBL] [Abstract][Full Text] [Related]
58. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.
Satoh K; Yachida S; Sugimoto M; Oshima M; Nakagawa T; Akamoto S; Tabata S; Saitoh K; Kato K; Sato S; Igarashi K; Aizawa Y; Kajino-Sakamoto R; Kojima Y; Fujishita T; Enomoto A; Hirayama A; Ishikawa T; Taketo MM; Kushida Y; Haba R; Okano K; Tomita M; Suzuki Y; Fukuda S; Aoki M; Soga T
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7697-E7706. PubMed ID: 28847964
[TBL] [Abstract][Full Text] [Related]
59. MYC and tumor metabolism: chicken and egg.
Dejure FR; Eilers M
EMBO J; 2017 Dec; 36(23):3409-3420. PubMed ID: 29127156
[TBL] [Abstract][Full Text] [Related]
60. CLDN6 Suppresses c-MYC-Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer.
Qu H; Qi D; Wang X; Dong Y; Jin Q; Wei J; Quan C
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
